Patients with a germline mutation in the breast cancer susceptibility genes Breast cancer 1 (BRCA1) or Breast cancer 2 (BRCA2) have a high risk of developing breast cancer or ovarian cancer [3] and show high sensitivity to these DNA damaging agents [4,5]. This evidence concerns the gene BRCA1 and ovarian carcinoma.